| P50 | author | Cynthia S Crowson | Q87215892 |
| | Daniel H Solomon | Q91503755 |
| | Mark A. Hlatky | Q56166694 |
| | John M. Davis | Q57081275 |
| P2093 | author name string | Eric L Matteson | |
| | Katherine P Liao | |
| | Keith L Knutson | |
| | Sherine E Gabriel | |
| P2860 | cites work | Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis | Q24601392 |
| | Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group | Q28138338 |
| | The pathogenesis of rheumatoid arthritis | Q29614957 |
| | Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study | Q29620671 |
| | EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 |
| | Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis | Q33646411 |
| | Autoantibodies and the risk of cardiovascular events | Q33721605 |
| | Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells | Q33967700 |
| | Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment | Q34093086 |
| | Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics | Q34233328 |
| | Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden | Q34307622 |
| | Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial | Q34327988 |
| | Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population | Q34346309 |
| | Benefits of exercise in rheumatoid arthritis | Q34591298 |
| | Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis | Q34648366 |
| | Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease | Q34684331 |
| | Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations | Q34712199 |
| | Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study | Q34897630 |
| | Preventive medical services among patients with rheumatoid arthritis. | Q35216076 |
| | Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease | Q35377706 |
| | Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial | Q35549517 |
| | Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. | Q35553700 |
| | Patterns of cardiovascular risk in rheumatoid arthritis | Q35638493 |
| | Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis | Q35899148 |
| | Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 |
| | CD28 extinction in human T cells: altered functions and the program of T-cell senescence | Q36121041 |
| | A reevaluation of aspirin therapy in rheumatoid arthritis | Q72545778 |
| | T-cell-mediated lysis of endothelial cells in acute coronary syndromes | Q77595337 |
| | Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis | Q79610823 |
| | Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study | Q79850163 |
| | Predictors of exercise and effects of exercise on symptoms, function, aerobic fitness, and disease outcomes of rheumatoid arthritis | Q80707217 |
| | Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study | Q80791227 |
| | Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis | Q80808131 |
| | Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis | Q80969856 |
| | Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition | Q81216018 |
| | Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 |
| | Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study | Q82354836 |
| | Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) | Q85063666 |
| | Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry | Q85214351 |
| | Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization | Q87405670 |
| | Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? | Q36327186 |
| | Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis | Q36907729 |
| | A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease | Q36954861 |
| | The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. | Q37074034 |
| | Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. | Q37089409 |
| | Telomerase insufficiency in rheumatoid arthritis | Q37132884 |
| | Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease | Q37151403 |
| | Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis | Q37273198 |
| | Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates? | Q37279687 |
| | Poor physical fitness and performance as predictors of mortality in normal populations and patients with rheumatic and other diseases. | Q37331974 |
| | Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). | Q37561659 |
| | Rejuvenating the immune system in rheumatoid arthritis | Q37607081 |
| | Tocilizumab for rheumatoid arthritis: a Cochrane systematic review | Q37800760 |
| | Systematic review and meta‐analysis: Anti–tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis | Q37801353 |
| | Atherosclerosis: current pathogenesis and therapeutic options | Q37953777 |
| | Expansion of unusual CD4+ T cells in severe rheumatoid arthritis | Q41496871 |
| | Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients | Q41933145 |
| | Subclinical peripheral arterial disease in rheumatoid arthritis | Q43018213 |
| | Outcomes in patients with rheumatoid arthritis and myocardial infarction. | Q43618212 |
| | Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis | Q44187483 |
| | Rheumatoid arthritis and macrovascular disease | Q44321557 |
| | Glucocorticoids and insulin sensitivity in rheumatoid arthritis | Q44881615 |
| | Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study | Q45205227 |
| | Simvastatin improves endothelial function in patients with rheumatoid arthritis | Q45244385 |
| | Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis | Q46068912 |
| | Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. | Q46632190 |
| | CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients | Q47438401 |
| | Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial | Q47622915 |
| | Effects of a modified dance-based exercise on cardiorespiratory fitness, psychological state and health status of persons with rheumatoid arthritis. | Q51128165 |
| | Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study. | Q51695204 |
| | Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity. | Q51890245 |
| | Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial. | Q53239672 |
| | Proinflammatory HLA-DRB1*01-haplotype predisposes to ST-elevation myocardial infarction. | Q53669495 |
| | Association between HLA-DRB1, HLA-DRQB1 alleles, and CD4+CD28null T cells in a Chinese population with coronary heart disease | Q54411384 |
| | Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. | Q55049410 |
| | The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years | Q57540261 |
| | Dyslipidaemia in Rheumatoid Arthritis: The Role of Inflammation, Drugs, Lifestyle and Genetic Factors | Q57751173 |
| | Effects of high-intensity resistance training in patients with rheumatoid arthritis: A randomized controlled trial | Q57915748 |
| | Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study | Q60298067 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| | cardiovascular disease | Q389735 |
| P304 | page(s) | 622-628.e1 | |
| P577 | publication date | 2013-08-29 | |
| P1433 | published in | American Heart Journal | Q2227156 |
| P1476 | title | Rheumatoid arthritis and cardiovascular disease | |
| P478 | volume | 166 | |